Replies to post #2398 on Zynerba Pharmaceuticals (ZYNE)

[Stockfun1]

Hmmm? Not sure I’d agree with that. The stock was $15 @ year ago. No revenues then and much better data out. My avg PPS is low $6 so it is regaining some of its losses but just frustrating. I am curious what others feel is a reasonable target price with an NDA announcement.